Biomarkers in uterine leiomyoma  

Oleh:

Levy, Gary ; Hill, Micah J. ; Plowden, Torie C. ; Catherino, William H. ; Armstrong, Alicia Y.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Fertility and Sterility (keterangan: ada di ClinicalKey) vol. 99 no. 04 (Mar. 2013), page 1146-1152.
Topik: GYNECOLOGICAL DISEASES; Leiomyoma; fibroids; biomarker

Ketersediaan

Perpustakaan FK Nomor Panggil: F02.K.2013.03 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Biomarkers are biologic compounds that are easily accessible and reflect normal physiology or pathology. They are useful in a variety of clinical situations that involve detection of subclinical disease, risk stratification, preoperative planning, and monitoring treatment. A useful intervention needs to exist for a biomarker to be an effective tool. Many compounds have been investigated as potential biomarkers for the diagnosis and surveillance of uterine leiomyomas. Most of these compounds demonstrate subtle differences among patients when leiomyomas are compared with controls. The compounds investigated lack the diagnostic accuracy necessary to add any benefit to the current available modalities used to diagnose and monitor uterine leiomyomas.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali